Literature DB >> 25172399

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Juan Carlos Plana1, Maurizio Galderisi2, Ana Barac3, Michael S Ewer4, Bonnie Ky5, Marielle Scherrer-Crosbie6, Javier Ganame7, Igal A Sebag8, Deborah A Agler1, Luigi P Badano9, Jose Banchs4, Daniela Cardinale10, Joseph Carver11, Manuel Cerqueira1, Jeanne M DeCara12, Thor Edvardsen13, Scott D Flamm1, Thomas Force14, Brian P Griffin1, Guy Jerusalem15, Jennifer E Liu16, Andreia Magalhães17, Thomas Marwick18, Liza Y Sanchez4, Rosa Sicari19, Hector R Villarraga20, Patrizio Lancellotti15.   

Abstract

Entities:  

Keywords:  Biomarkers; Chemotherapy; Doxorubicin; Early detection; Left ventricular dysfunction; Strain; Three-dimensional echocardiography; Trastuzumab

Mesh：

Year:  2014        PMID： 25172399     DOI： 10.1016/j.echo.2014.07.012

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN： 0894-7317            Impact factor:   5.251


× No keyword cloud information.
  309 in total

1.  Illuminating anthracycline cardiotoxicity: the renaissance of evidence-based onco-cardiology.

Authors:  Isaac B Rhea; Guilherme H Oliveira
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  Imaging and chemotherapy cardiotoxicity: A long-playing story still seeking precision and improved outcomes/management data.

Authors:  William A Van Decker
Journal:  J Nucl Cardiol       Date:  2015-09-04       Impact factor: 5.952

Review 3.  Reference Ranges of Left Ventricular Strain Measures by Two-Dimensional Speckle-Tracking Echocardiography in Children: A Systematic Review and Meta-Analysis.

Authors:  Philip T Levy; Aliza Machefsky; Aura A Sanchez; Meghna D Patel; Sarah Rogal; Susan Fowler; Lauren Yaeger; Angela Hardi; Mark R Holland; Aaron Hamvas; Gautam K Singh
Journal:  J Am Soc Echocardiogr       Date:  2015-12-30       Impact factor: 5.251

Review 4.  Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.

Authors:  Chandra K Ala; Allan L Klein; Javid J Moslehi
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

5.  Early Myocardial Strain Changes During Potentially Cardiotoxic Chemotherapy May Occur as a Result of Reductions in Left Ventricular End-Diastolic Volume: The Need to Interpret Left Ventricular Strain With Volumes.

Authors:  Jennifer H Jordan; Bunyapon Sukpraphrute; Giselle C Meléndez; Marie-Pierre Jolly; Ralph B D'Agostino; W Gregory Hundley
Journal:  Circulation       Date:  2017-06-20       Impact factor: 29.690

Review 6.  Cardiac MRI for the evaluation of oncologic cardiotoxicity.

Authors:  Adrián I Löffler; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2018-05-07       Impact factor: 5.952

Review 7.  Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges.

Authors:  Debashish Das; Alex Asher; Arjun K Ghosh
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

8.  Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy.

Authors:  Christian Cadeddu; Alessandra Piras; Mariele Dessì; Clelia Madeddu; Giovanni Mantovani; Mario Scartozzi; Andreas Hagendorff; Paolo Colonna; Giuseppe Mercuro
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-01       Impact factor: 2.357

9.  Effects of Exercise Therapy Dosing Schedule on Impaired Cardiorespiratory Fitness in Patients With Primary Breast Cancer: A Randomized Controlled Trial.

Authors:  Jessica M Scott; Samantha M Thomas; Jeffrey M Peppercorn; James E Herndon; Pamela S Douglas; Michel G Khouri; Chau T Dang; Anthony F Yu; Diane Catalina; Cristi Ciolino; Catherine Capaci; Meghan G Michalski; Neil D Eves; Lee W Jones
Journal:  Circulation       Date:  2020-02-17       Impact factor: 29.690

Review 10.  Cardiovascular imaging in cardio-oncology.

Authors:  Amir Abbas Mahabadi; Christoph Rischpler
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.